Rationale: Programs to prevent the incidence rate of tuberculosis (TB) from increasing in many low-incidence countries are challenged by international travel and immigration from high-burden countries.
Objectives: The current study aimed to determine the effect of such immigration on the genetic diversity of Mycobacterium tuberculosis isolates in an entire nation's population during 1994–2005.
Methods: A total of 3,131 patients were notified with TB during the 12-year period. Of these, 2,284 (73%) had TB verified by culture, and isolates from 2,173 (96%) of these were analyzed by IS6110 restriction fragment length polymorphism.
Measurements and Main Results: Only 31% of the included strains were isolated from nonimmigrants, the remaining 69% were isolated from immigrants. Although the incidence increased throughout the period, the genetic diversity remained high. A total of 135 clusters were identified; the percentage of recent disease was reduced among nonimmigrants, and remained stable among the immigrants during the study period. Although 69% of the isolates originated from immigrants from high-incidence countries, the established TB control program in the receiving country was adequate for the prevention of disease transmission. On average per year, only 2 nonimmigrants and 13 immigrants developed disease as a result of infection within the country by imported M. tuberculosis.
Conclusions: Twelve years of M. tuberculosis importation as a result of immigration from high-incidence countries had little influence on the transmission of this pathogen in the receiving low-incidence country. To prevent future increase of transmission of TB, the current control strategies of low-incidence countries are adequate but must be maintained.
It is commonly expected that immigrants with tuberculosis (TB), imported to low-incidence countries, present a challenge to control programs of the receiving countries.
Immigration did not appear to result in increased transmission of TB. The TB situation among resident nonimmigrants and immigrants was not significantly affected by new arrivals. Importation of TB may not affect public health in the population of the recipient country.
The Norwegian TB control program is based on a national regulation from the Ministry of Health and Care Services (13). It requires all counties to establish and implement TB control programs to ensure case-finding and case-holding activities. Early diagnosis and adequate treatment under direct supervision remain the main strategy, in addition to increased use of treatment of latent infection. Asylum seekers and immigrants from high-incidence countries are screened on arrival by use of chest radiograph and tuberculin skin test. In addition, contact tracing is done in cases of infectious pulmonary disease. Identification of isolates is confirmed, and restriction fragment length polymorphism (RFLP) characterization is performed on all positive Mycobacterium tuberculosis cultures at the National Reference Laboratory for Mycobacteria, the Department of Bacteriology and Immunology, Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH).
A national registry compares notifications of diagnosis of TB made by clinicians, antituberculosis drug prescriptions handled by pharmacies, and positive M. tuberculosis cultures reported by laboratory staff. Because of this triple reporting system, notifications are quite complete. The facilitated network of county TB coordinators further ensures the follow-up of individual cases. Mycobacterium bovis bacillus Calmette-Guérin immunization is offered to all teenagers, in addition to newly born infants of parents from high-incidence countries. Health services are free of charge for all, and sick leave is financially compensated by the government. Patients with TB are not deported while still receiving treatment.
Increasing number of immigrants arriving from high-incidence countries may justify changes or adaptations to TB control programs (10). One important potential impact of imported TB cases from high-incidence countries to low-incidence countries would be an increase in the rate of transmission in the recipient country. The impact of such import is difficult to measure or forecast, due to incomplete strain collections, low levels of transmission, and the chronic nature of TB. However, the comparison of complete M. tuberculosis collections is feasible in some small countries, due to the manageable number of M. tuberculosis strains present. In addition, the fact that patients may stay latently infected for many years before they develop symptoms of active TB means extended observation periods are required.
In the current study, we describe the molecular epidemiology of the complete M. tuberculosis population of a low-incidence country over 12 years. The data presented may serve as a model for the TB epidemics of current and future low-incidence countries that draw immigrants from various high-incidence parts of the world.
The study population comprised 96% of all patients in Norway from whom at least one sample positive for M. tuberculosis by culture was collected during 1994–2005. A total of 14 microbiological laboratories, servicing the entire nation, performed the isolation of M. tuberculosis from patient samples. Patient information was collected at the Department of Infectious Disease Epidemiology, NIPH. The Department of Bacteriology and Immunology, NIPH, including the National Reference Laboratory for Mycobacteria, received all M. tuberculosis isolates and performed IS6110 RFLP analysis. During this period, 3,131 patients were notified with TB, and cultures of M. tuberculosis were recovered from 2,284 of these patients. A total of 2,214 of these isolates were received, analyzed consecutively, and included in the national RFLP database. Denominators used to calculate the incidence of TB in Norway were extrapolated from Statistics Norway (http://www.ssb.no). The case detection rate was calculated as the number of cases notified divided by the number of cases estimated for that year and was expressed as a percentage. For Norway, during 1995–2005, these percentages were 57, 61, 60, 70, 70, 77, 102, 93, 127, 113, and 112%, respectively (http://www.who.int). This demonstrated that, during the latter years of the study, more cases were detected than the estimated number of cases and the case detection rate was considered to increase.
Species identification of the isolates was based on a 16S-rDNA hybridization technique (AccuProbe; GenProbe, Inc., San Diego, CA) and standard microbiological tests (nitrate reduction and niacin accumulation tests). For this study, people born abroad were referred to as immigrants and people born in Norway to Norwegian or immigrant parents were called native or nonimmigrants. Throughout this article, 1 year implies the calendar period from January 1 until December 31.
The analyses included the IS6110 RFLP for all strains to track possible transmission and determine genetic diversity, as described previously (4). In addition, we selected all isolates from 2003–2005 that could be considered members of the M. tuberculosis Beijing family (5). These were studied further by spoligotyping to ensure that there was no transmission specific to this family. A total of 308 isolates with less than five copies of IS6110 were excluded from the current analysis.
The IS6110 fingerprint patterns and spoligopatterns were compared by visual examination and computer-assisted analyses by use of BioNumerics, version 1.5, software (Applied Maths, Kortrijk, Belgium). To facilitate the comparison of the fingerprints, normalization was done using the molecular weight standards run on each gel. Similarity measures were calculated using the Dice coefficient, allowing 1.0% position tolerance. Cluster analysis was performed using the unweighted pair–group average method. Clusters were defined as groups of strains with 100% identical IS6110 RFLP patterns. This analysis was repeated, allowing clusters to also include strains with 80% identical RFLP patterns and differing in one or two bands. The patterns obtained with the spoligotyping were compared by visual examination and computer-assisted sorting of the results in an Excel sheet (Microsoft Excel 97; Microsoft Corporation, Redmond, WA). Although the latency period may vary considerably between different individuals, a secondary case was defined as an isolate with a fingerprint pattern identical to at least one previously isolated strain.
The population diversity was calculated by dividing the number of different IS6110 RFLP patterns by the number of isolates fingerprinted each year. The degree of clustering was calculated continuously, and for each year, by dividing the numbers of isolates in clusters per number of fingerprinted isolates. We included linear regression analyses (SigmaPlot 9.0; Systat Software, Inc., San Jose, CA) to illustrate the trends of change in the M. tuberculosis population through the 12-year period, and 95% confidence intervals are given in Figures 1, 3, and 4.
The incidence of TB showed a steady increase throughout the study period, from 4.7 to 7.2 per 100,000 population (Figure 1). This was due to an increasing number of immigrants notified with the disease, whereas the incidence among nonimmigrants was declining (Figure 2). Repeated samples from individual patients that were found to be identical by use of IS6110 RFLP were removed from the database. The genetic diversity remained high, indicating limited transmission to both immigrants and nonimmigrants residing within the country.
Of the 2,214 strains, 41 (1.9%) were reported as possible cases of laboratory cross-contamination (identical RFLP patterns in strains isolated from different patients within the same laboratory during the same week). These cases of cross-contamination included 23 episodes. One included 7 false positive samples, 2 episodes each included 4, 3, and 2 false positive samples, and 16 episodes included single samples originally expected to be negative for M. tuberculosis. The cases were observed in 11 laboratories. The strains were excluded from further analyses. Eleven of the 41 patients had initiated treatment for TB by the time the false-positive results were suspected.
After exclusion of the suspected laboratory cross-contaminants, 2,173 strains remained. A total of 671 (31%) patients were nonimmigrants and 1,502 (69%) were immigrants. During the 12-year period, the percentage of immigrants living in the country had increased from 4.8 to 7.9% (Statistics Norway; http://www.ssb.no) and the proportion of immigrants among the patients notified with TB increased significantly, from 46% in 1994, to 78% in 2005. The majority of immigrants diagnosed with TB originated from Somalia, Pakistan, the former Yugoslavia, Ethiopia, Vietnam, Thailand, the former Soviet Union, and India. The remaining patients originated from 36 additional countries, with fewer than 10 patients from each country. The patients were 0 to 97 years old. The average age of Norwegian patients was 66 years (median age, 73 yr) and for the immigrant patients the average age was 33 years (median age, 31 yr). The HIV status of the patients included in this study was, in most cases, not known. Although HIV testing is recommended in TB cases, the result is not reported to the TB registry. HIV is, however, not widespread in Norway. Fewer than 200 new cases are notified per year and more than half represent newly arrived immigrants, who were infected before their arrival (14). During 1984–2005, a total of 3,264 HIV-positive cases were notified within the country. All HIV-positive patients are supposed to be screened for latent TB and preventive treatment is recommended to individuals infected with M. tuberculosis (15).
During 1986–2002, the median observation period between arrival to the country and TB notification for all cases was 1.5 years (range, 0–15.4 yr). Immigrants from Asia, Latin-America and the Caribbean, Africa, and Europe (excluding the Nordic countries) had median intervals of 2.1, 1.6, 1.4, and 0.5 years, respectively (16). Few cases were diagnosed by compulsory screening on arrival (19 in 2005), thus active TB developed after immigration.
The data included in the current analyses are given in Table 1. A total of 1,865 isolates carried more than four copies of IS6110. These were distributed among 1,615 different RFLP patterns, thus the genetic diversity of the M. tuberculosis population in Norway during these 12 years was 87% (Table 1). The number of different RFLP patterns plotted against the number of isolates analyzed corroborated that the diversity in the M. tuberculosis population remained stable despite the 12-year increase in the M. tuberculosis importation. The diversity remained high during the 12-year period (Figure 3). The low diversity in 1996 was a result of three major outbreaks, and the overall low number of strains isolated that year (4, 17). The incidences of TB due to clustered M. tuberculosis isolates as well as unique M. tuberculosis isolates are given in Table 1.
Population | Incidence | No. Culture Positive | No. Clustered Isolates | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Year | Total | Immigrant | Notified Cases | Unique Patterns | Clustered Patterns | All Cases | Incidence per 100,000 | Nonimmigrants | Immigrants | Unique- Pattern Isolates (n) | Clustered Isolates, n (%) | Among Nonimmigrants | Among Immigrants | Within Same Year | |||||||
1994 | 4,324,815 | 205,598 | 5.6 | 2.3 | 0.39 | 118 | 2.7 | 69 | 49 | 101 | 17 (14) | 11 | 6 | 12 | |||||||
1995 | 4,348,410 | 215,048 | 5.4 | 2.0 | 0.37 | 105 | 2.4 | 61 | 44 | 89 | 16 (15) | 8 | 8 | 11 | |||||||
1996 | 4,369,957 | 223,797 | 5 | 2.0 | 0.92 | 126 | 2.9 | 72 | 54 | 86 | 40 (31) | 31 | 9 | 25 | |||||||
1997 | 4,392,714 | 232,192 | 4.7 | 2.1 | 0.66 | 122 | 2.8 | 58 | 64 | 93 | 29 (23) | 11 | 18 | 14 | |||||||
1998 | 4,417,599 | 244,705 | 5.5 | 2.6 | 0.70 | 145 | 3.3 | 71 | 74 | 114 | 31 (21) | 14 | 17 | 11 | |||||||
1999 | 4,445,329 | 260,742 | 6.2 | 2.7 | 0.88 | 161 | 3.6 | 58 | 103 | 122 | 39 (24) | 10 | 29 | 19 | |||||||
2000 | 4,478,497 | 282,487 | 5.3 | 2.3 | 0.69 | 136 | 3.0 | 46 | 90 | 105 | 31 (22) | 9 | 22 | 12 | |||||||
2001 | 4,503,436 | 297,731 | 6.6 | 3.5 | 0.75 | 192 | 4.3 | 47 | 145 | 158 | 34 (17) | 7 | 27 | 15 | |||||||
2002 | 4,524,066 | 310,704 | 6.2 | 2.6 | 0.73 | 151 | 3.3 | 40 | 111 | 118 | 33 (21) | 6 | 27 | 14 | |||||||
2003 | 4,552,252 | 332,793 | 7.4 | 3.9 | 0.94 | 220 | 4.8 | 46 | 174 | 177 | 43 (19) | 5 | 38 | 27 | |||||||
2004 | 4,577,457 | 348,940 | 6.6 | 3.8 | 0.68 | 207 | 4.5 | 39 | 168 | 176 | 31 (15) | 5 | 26 | 18 | |||||||
2005 | 4,606,363 | 364,981 | 6.2 | 3.1 | 0.89 | 182 | 4.0 | 33 | 149 | 141 | 41 (22) | 6 | 35 | 21 | |||||||
Total | 1,865 | 640 | 1,225 | 1,480 | 385 | 123 | 262 |
The percentages of cases due to clustered isolates are given in Table 1. The rate of patients infected by TB caused by isolates carrying unique RFLP patterns increased throughout the study period. The rate of clustered isolates, however, was stable during 1996–2005 (Table 1). Regression analysis demonstrated that this rate remained around 0.8 during the study (data not shown). Thus, the increasing incidence of TB in this country represented an increase in RFLP-unique cases among immigrants.
A total of 385 isolates were assigned to 135 clusters. Only 13 clusters included more than five patients and all these clusters had index cases notified before 2000. The index cases of 10 of these major outbreaks were of foreign origin and three were of nonimmigrant origin. Only 16 of the 135 clusters included strains isolated from both immigrants and natives. Although the IS6110 RFLP patterns of M. tuberculosis are fairly stable (18), a number of outbreaks and community-based studies have observed that IS6110-RFLP patterns may evolve during ongoing transmission (19). If a cluster was defined as two or more strains with 80% similarity and that the RFLP patterns differed by one or two bands, the total number of clustered isolates increased to 494 isolates assigned to 143 clusters. In most cases, this led to an increased number of strains included in the above-mentioned clusters. In some cases, however, it led to the convergence of existing clusters or introduced new ones. Due to the high stability of IS6110 (18, 19), this definition of a cluster is considered to overestimate the level of transmission. However, even with this assumption, the degree of clustering was very low and it confirmed that the analysis did not greatly underestimate the transmission level in the current setting.
The number of clustered strains is expected to increase in parallel with an increasing number of RFLP-typed strains available in a database (20). We thus also calculated the percentage of patients who had a clustered isolate within a 24-month period (8). Defining clustering within a 2-year period is expected to represent strains that lead to rapid progression to disease (21). When a 24-month period was used as a clustering interval, among the nonimmigrant group the proportions of clustered cases gradually decreased during 1994–2005, whereas, among the immigrants, these proportions remained stable (Figure 4). This will also ensure a similarly sized RFLP database for all isolates. Although the overall incidence of TB increased, the percentage of clustered M. tuberculosis isolates remained stable during the last decade. The increasing incidence was due to M. tuberculosis isolates carrying unique RFLP patterns (Figure 5).
The number of RFLP patterns observed among the M. tuberculosis isolates for each year increased throughout the period, as did the number of unique RFLP patterns observed each year (Table 1). This supported the observation that importation of M. tuberculosis did not lead to increased levels of transmission and that the established TB control program could control the imported M. tuberculosis.
Strains within the Beijing lineage of M. tuberculosis are known to have disseminated globally in recent years and are commonly associated with hypervirulence and outbreaks (5, 22). It is therefore expected to be well suited as an indicator strain for recently imported M. tuberculosis. Among the included 609 strains that were isolated during 2003–2005 (Table 1), 286 carried an RFLP pattern that had at least 10 copies of IS6110 or 60% IS6110 RFLP homology to 1 of 19 predefined representative strains of the M. tuberculosis Beijing family. A total of 150 of these were available for spoligotyping, and it was confirmed that 19 isolates belonged to this lineage. None of the Beijing isolates was part of a cluster based on the IS6110 RFLP analyses. It was therefore concluded that the Beijing lineage was present in the country but it was unable to cause outbreaks in the current low-incidence setting.
The number of strains isolated from the immigrant population within the country increased during the 12 years and decreased for the nonimmigrants (Figure 5). This was believed to reflect the changing origin of the immigrants living within the country and illustrated how quickly a considerable change in the population of patients with TB may occur in low-incidence countries. The incidence of TB increased significantly during these years (Figure 1), and the percentage of immigrants among the patients with TB increased throughout the period (Figure 2). Thus, the increasing incidence of TB was attributed to importation of M. tuberculosis by immigration. However, the proportion of clustered isolates remained low among both immigrants and nonimmigrants.
A total of 250 secondary TB cases were diagnosed among the culture-positive cases during the 12-year period. Only 75 of these were nonimmigrants, and 175 were immigrants. Among the nonimmigrants, only 23 were infected with an M. tuberculosis strain believed to be imported due to its previous isolation from a patient of foreign origin. Among the immigrants, 159 were for the same reason expected to have been infected within the country by an imported strain. Individuals may, however, also have been infected by identical strains outside the country. Thus, our assumption may overestimate the number of individuals infected within the country, but it is not likely to underestimate the level of transmission. It was demonstrated that, on average, a maximum of 2 nonimmigrants and 13 immigrants developed TB disease after infection within the country each year by imported M. tuberculosis strains. Even when strains with 80% similarity and one to two different RFLP bands were clustered (data not shown), only 351 secondary cases were found. This supported the conclusion that transmission of imported M. tuberculosis within the current country was very low.
It is well known that much of the TB in Australia, Canada, Europe, and the United States occurs in foreign-born people and that the risk of TB is great in the first years after arrival in the host country (12, 20, 23–32). However, TB can persist within immigrant communities for extended periods, and the prevalence of the disease increases with age (7, 29, 33–35). It is therefore less clear how importation of pathogens influence local populations over extended periods, such as years or decades, because detailed characterizations of complete microbial collections are difficult to obtain. Also, due to the chronic nature of TB and the persistence of substantial immigrant populations with latent TB in low-incidence countries (29), it may take many years before the full impact of imported TB can be measured.
In the current study, immigrants represented the majority of TB cases, and all strains of M. tuberculosis isolated within an entire country during 12 years were analyzed by IS6110 RFLP. The number of notified TB cases within the country increased during these years. The percentage of immigrants increased in general and among patients with TB. Each year, a few additional patients developed disease due to established strains but slightly less than one significant outbreak was detected for each year of the study (10 outbreaks in 12 yr). Among the strains initially isolated from immigrants during the 12 years, only 10 were able to establish an epidemic that included more than five patients within 5 years. This inability to establish outbreaks included the Beijing lineage, members of which are commonly believed to harbor increased ability for transmission. This indicated that the importation of M. tuberculosis isolates did not represent an immediate challenge to the national TB control program.
It was demonstrated that the number of clustered isolates among nonimmigrants declined during the study period, despite the import of foreign strains. The proportion of clustered isolates among immigrants was stable during the 12 years.
Transposition of IS6110 apparently depends on strain-specific properties and allows changes in RFLP patterns during ongoing transmission (19, 21, 36). IS6110 RFLP studies are, however, regarded as sufficiently stable to allow study of transmission dynamics of M. tuberculosis over time (19). The public debate on immigration to wealthy countries has often focused on the negative effects immigration may have on public health. Immigrants have been accused of spreading TB. However, the current study demonstrated that importation of M. tuberculosis, over 12 years, did not generate significant negative effects on the transmission of TB in a country that was considered to be in the elimination phase of this disease (37). Although the current study did not include individuals with latent M. tuberculosis infection, the number of M. tuberculosis strains isolated from nonimmigrants declined continuously throughout the 12-year period (Table 1), and immigration did not appear to influence the TB situation among the existing residents of the country.
In the current 12-year study, importation of M. tuberculosis led to an increased incidence of TB during the period, but otherwise had little effect on the TB situation in this low-incidence setting. The social situation of the immigrant population is expected to have changed during the 12-year period, as has the size of this group. Such changes may in part explain the changing TB epidemiology. However, the low number of clustered strains could not support the statement that public health in this recipient country was hampered by immigration from high-incidence countries. It appeared that the TB control efforts were not overwhelmed by the challenge of imported TB. The national control program against TB in Norway is comparable to that of most other low-incidence countries (38, 39). The strategies used mainly include active entry screening of immigrants, contact tracing of notified infectious cases, and directly observed treatment. A national registry ensures updated surveillance data, and the network of county-level TB coordinators monitors the follow-up of individual cases. If these control strategies are well maintained, elimination of indigenous transmission of TB could be achievable, despite extensive import from high-incidence countries.
The authors acknowledge the microbiological laboratories in Norway for sending in their M. tuberculosis isolates to the Norwegian Institute of Public Health (NIPH). They thank the staff at the NIPH for their skillful assistance. They are also grateful to Richard M. Anthony, Royal Tropical Institute, Amsterdam, The Netherlands, for revising the manuscript.
1. | Barnes PF, Yang Z, Pogoda JM, Preston-Martin S, Jones BE, Otaya M, Knowles L, Harvey S, Eisenach KD, Cave MD. Foci of tuberculosis transmission in central Los Angeles. Am J Respir Crit Care Med 1999;159:1081–1086. |
2. | Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ, Metchock B, Khan A, Burman WJ; the Tuberculosis Trials Consortium. Recurrent tuberculosis in the United States and Canada: relapse or reinfection? Am J Respir Crit Care Med 2004;170:1360–1366. |
3. | Coker R, Bell A, Pitman R, Zellweger JP, Heldal E, Hayward A, Skulberg A, Bothamley G, Whitfield R, de Vries G, et al. Tuberculosis screening in migrants in selected European countries shows wide disparities. Eur Respir J 2006;27:801–807. |
4. | Dahle UR, Sandven P, Heldal E, Caugant DA. Continued low rates of transmission of Mycobacterium tuberculosis in Norway. J Clin Microbiol 2003;41:2968–2973. |
5. | Kremer K, Glynn JR, Lillebaek T, Niemann S, Kurepina NE, Kreiswirth BN, Bifani PJ, van Soolingen D. Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol 2004;42:4040–4049. |
6. | Schwartzman K, Menzies D. Tuberculosis screening of immigrants to low-prevalence countries. a cost-effectiveness analysis. Am J Respir Crit Care Med 2000;161:780–789. |
7. | Bloom BR. Tuberculosis: the global view. N Engl J Med 2002;346:1434–1435. |
8. | de Vries G, van Hest RAH, Richardus JH. Impact of mobile radiographic screening on tuberculosis among drug users and homeless persons. Am J Respir Crit Care Med 2007;176:201–207. |
9. | Dasgupta K, Schwartzman K, Marchand R, Tennenbaum TN, Brassard P, Menzies D. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med 2000;162:2079–2086. |
10. | Chin DP, Deriemer K, Small PM, de Leon AP, Steinhart R, Schecter GF, Daley CL, Moss AR, Paz EA, Jasmer RM, et al. Differences in contributing factors to tuberculosis incidence in U.S.-born and foreign-born persons. Am J Respir Crit Care Med 1998;158:1797–1803. |
11. | Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2006;174:736–742. |
12. | Enarson DA. Tuberculosis: 12. Global disease and the role of international collaboration. CMAJ 2000;162:57–61. |
13. | Ministry of Health and Care Services. Elimination of tuberculosis? [in Norwegian] Norwegian Official Report 1998:3. |
14. | Aavitsland P, Nilsen Ø. HIV-infection in Norway before 2006. Tidsskr Nor Laegeforen 2006;126:3125–3130. |
15. | Ormaasen V, Mæland A. Tuberkulose hos HIV-smittede i Norge [in Norwegian]. Tidsskr Nor Laegeforen 2001;121:3425–3430. |
16. | Farah MG, Meyer HE, Selmer R, Heldal E, Bjune G. Long-term risk of tuberculosis among immigrants in Norway. Int J Epidemiol 2005;34:1005–1011. |
17. | Dahle UR, Sandven P, Heldal E, Mannsaaker T, Caugant DA. Deciphering an outbreak of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2003;41:67–72. |
18. | Arnold C. Molecular evolution of Mycobacterium tuberculosis. Clin Microbiol Infect 2007;13:120–128. |
19. | Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 2006;19:658–685. |
20. | Maguire H, Dale JW, McHugh TD, Butcher PD, Gillespie SH, Costetsos A, Al-Ghusein H, Holland R, Dickens A, Marston L, et al. Molecular epidemiology of tuberculosis in London 1995–7 showing low rate of active transmission. Thorax 2002;57:617–622. |
21. | Jasmer RM, Hahn JA, Small PM, Daley CL, Behr MA, Moss AR, Creasman JM, Schecter GF, Paz EA, Hopewell PC. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991–1997. Ann Intern Med 1999;130:971–978. |
22. | Hanekom M, van der Spuy GD, Streicher E, Ndabambi SL, McEvoy CRE, Kidd M, Beyers N, Victor TC, van Helden PD, Warren RM. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family was associated with an increased ability to spread and cause disease. J Clin Microbiol 2007;45:1483–1490. |
23. | Talbot EA, Moore M, McCray E, Binkin NJ. Tuberculosis among foreign-born persons in the United States, 1993–1998. JAMA 2000;284:2894–2900. |
24. | Murray MB. Molecular epidemiology and the dynamics of tuberculosis transmission among foreign-born people. CMAJ 2002;167:355–356. |
25. | American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America. Controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005;172:1169–1227. |
26. | Hernandez-Garduno E, Kunimoto D, Wang L, Rodrigues M, Elwood RK, Black W, Mak S, FitzGerald JM. Predictors of clustering of tuberculosis in Greater Vancouver: a molecular epidemiologic study. CMAJ 2002;167:349–352. |
27. | Wobeser WL, Yuan L, Naus M, Corey P, Edelson J, Heywood N, Holness DL. Expanding the epidemiologic profile: risk factors for active tuberculosis in people immigrating to Ontario. CMAJ 2000;163:823–828. |
28. | Cowie RL, Sharpe JW. Tuberculosis among immigrants: interval from arrival in Canada to diagnosis. A 5-year study in southern Alberta. CMAJ 1998;158:599–602. |
29. | Heywood N, Kawa B, Long R, Njoo H, Panaro L, Wobeser W. Guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arriving in Canada: a summary. CMAJ 2003;168:1563–1565. |
30. | Bhatti N, Law MR, Morris JK, Halliday R, Moore-Gillon J. Increasing incidence of tuberculosis in England and Wales: a study of the likely causes. BMJ 1995;310:967–969. |
31. | Campbell IA, Bah-Sow O. Pulmonary tuberculosis: diagnosis and treatment. BMJ 2006;332:1194–1197. |
32. | Coker R. Compulsory screening of immigrants for tuberculosis and HIV. BMJ 2004;328:298–300. |
33. | Zuber PL, McKenna MT, Binkin NJ, Onorato IM, Castro KG. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA 1997;278:304–307. |
34. | Lillebaek T, Andersen AB, Bauer J, Dirksen A, Glismann S, de Haas P, Kok-Jensen A. Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol 2001;39:855–861. |
35. | Lillebaek T, Andersen ÅB, Dirksen A, Smith E, Skovgaard LT, Kok-Jensen A. Persistent high incidence of tuberculosis in immigrants in a low-incidence country. Emerg Infect Dis 2002;8:679–684. |
36. | van der Spuy GD, Warren RM, Richardson M, Beyers N, Behr MA, van Helden PD. Use of genetic distance as a measure of ongoing transmission of Mycobacterium tuberculosis. J Clin Microbiol 2003;41:5640–5644. |
37. | Van Embden J, Van Soolingen D. Molecular epidemiology of tuberculosis: coming of age [editorial]. Int J Tuberc Lung Dis 2000;4:285–286. |
38. | Evans MR. Is tuberculosis taken seriously in the UK? BMJ 1995;311:1483–1485. |
39. | Baltussen R, Floyd K, Dye C. Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ 2005;331:1364–1369. |